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The present work describes the development of a new high performance liquid chromatographic (HPLC) 
method for the determination of Cefixime trihydrate under different stress conditons as specified by ICH. 
For the analysis, a Phenomenex (250 x 4.6 mm, 5 µm particle size) ODS column and a SPD 20 A UV 
detector at 289 nm was used. The selected mobile phase was 10 mM disodium hydrogen phosphate (with 
0.5% TEA, pH adjusted to 6.3 with OPA) and methanol in the ratio of 75:25 (v/v) in isocratic mode at a 
flow rate of 1 mL.min-1.The linear regression analysis data for the calibration plots showed good linear 
relationship with r2 = 0.9997 in the concentration range of 5-100 μg.mL-1. The stress degradation was 
performed using acid, alkali, water, hydrogen peroxide and uv light.
Uniterms: High Performance Liquid Chromatography/quantitative analysis. Degradation. Stability-
indicating. Cefixime trihydrate/determination.
O presente trabalho descreve o desenvolvimento de um novo alta performance cromatografia líquida 
(HPLC) método para a determinação de cefixima tri-estresse sob diferentes condições, conforme 
especificado pelo ICH. Para a análise, a Phenomenex (250 x 4,6 mm, 5 µm de granulometria) ODS 
coluna e a SPD 20 um detector de UV em 289 nm foi utilizado. A fase móvel selecionado foi de 10 mM 
hidrogenofosfato dissódico (com 0,5% TEA, o pH ajustado para 6,3 com OPA) e de metanol em razão 
de 75:25 (v/v) no modo isocrático com uma taxa de fluxo de 1 mL.min-1. A análise de regressão linear 
para dados da calibração parcelas apresentaram boa relação linear com r2 = 0,9997 no intervalo de 
concentração de cerca de 5 100 µg.mL-1. Degradação do estresse foi realizado utilizando um ácido, 
alcalino, a água, o peróxido de hidrogênio e luz uv.
Unitermos: Cromatografia líquida de alto desempenho/análise quantitativa. Degradação. Indicador de 
estabilidade. Cefixima triidratada/determinação.
INTRODUCTION
Cefixime trihydrate (Chemical structure is given 
in Figure I) [(6R,7R)-7-(2-(2-amino-4-thiazolyl)
glyoxylamido]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]
oct-2-ene-2-carboxylic acid, 72-(Z)-[O-(carboxymethyl) 
oxime] is an orally absorbed third generation cephalosporin 
antibiotic that was approved by the U.S. Food and Drug 
Administration in 1997 for the treatment of mild to 
moderate bacterial infections. It has a broad antibacterial 
spectrum against various Gram-positive and Gram-
negative bacteria, including Haemophilus influenzae, 
Neisseria gonorrhoeae, Escherichia coli and Klebsiella 
pneumoniae resistant to ampicillin, cephalexin, cefaclor 
and trimethoprim - sulfamethoxazole. It is used for the 
treatment of susceptible infections, including gonorrhea, 
otitis media, pharyngitis, lower respiratory-tract infections 
such as bronchitis and urinary-tract infections (Brogden, 
Richards, 1989; Sweetman, 2002; Zahra Talebpour et al., 
2013).
Cefixime degrades under storage conditions 
(temperature and relative humidity) and its degradation 
products can cause undesirable side effects in patients 
(Kitamura et al., 1989; Kitamura et al., 1990). A detailed 
literature survey has shown that cefixime has been studied 
by various analytical methods like spectrophotometric 
(El-Walily et al., 2002; Attimarad et al., 2011), fluorimetric 
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(Bebawy, El-Kelani, Fattah, 2003), voltammetric (Golcu, 
Dogan, Ozkan, 2005; Jain et al., 2010), HPLC (Dhoka, 
Sandage, Dumbre, 2010; Arshad et al., 2009; Khan et 
al., 2008; Shah, Pundarikakshudu, 2006; Manna, Valvo, 
2004; Meng et al., 2005; Gonzalez-Hernandez et al., 2001; 
Khandagle, 2011), and HPTLC (Singh, Maheshwari, 
2010; Eric-Jovanovic et al., 1998; Pawar et al., 2010).
Although different analytical methods are available, 
a more economical stability indicating analytical method 
is developed for cefixime. We have forcefully degraded 
the drug (standard) under different stress conditions and 
developed an HPLC method that can differentiate the pure 
drug from its degradants. In an attempt to practice green 
chemistry and also to develop a cost effective analytical 
method, we have tried to minimise the use of organic 
solvent (ie methanol to 25%).
The International Conference on Harmonization 
(ICH) guideline entitled “Stability Testing of New Drug 
Substances and Products” requires that stress testing be 
carried out to elucidate the inherent stability characteristics 
of the active substance (ICH, 2005). Acidic, alkaline, 
oxidative, and photolytic stabilities are required. An 
ideal stability indicating method is the one that quantifies 
the standard drug alone and also resolves it from its 
degradation products (Bakshi, Singh, 2002).
EXPERIMENTAL
Material and reagents
Cefixime trihydrate (CEF) API was available as 
gift sample from Dr.Reddys Lab, Hyderabad. Methanol, 
disodium hydrogen phosphate and potassium dihydrogen 
phosphate were purchased from S.D Fine Chemicals 
(Mumbai, India) and were of HPLC grade. Hydrochloric 
acid, sodium hydroxide, hydrogen peroxide and 
orthophosphoric acid were purchased from S.D Fine 
Chemicals (Mumbai, India) and were of A.R grade. HPLC 
grade water was prepared in house by the triple distillation 
of water followed by filtration through filter paper of 
0.45 μm pore size. The standard solution of 100 µg/mL, 
prepared from the API was used for injection onto the 
HPLC column. The dosage forms used were Cefigip and 
Taxim-O each of which contained 200 mg per tablet.
HPLC instrumentation and chromatographic 
conditions
The HPLC system consists of a Shimadzu LC 20 
AD binary pump and SPD 20 A UV detector. The column 
consists of Phenomenex (250 mm length, 4.6 mm internal 
diameter, 5 µm particle size) Luna ODS column. LC 
Solution software was used for data acquisition. Sample 
injection was done by Rheodyne manual Injector. For 
the analysis, isocratic mode was selected and the mobile 
phase is a mixture of methanol and phosphate buffer 
(pH 6.8) in the ratio of 25:75. Phosphate buffer is prepared 
with 5.04 g of disodium hydrogen phosphate and 3.01 g 
potassium dihydrogen phosphate dissolved in 1000 mL 
of triple distilled water. The mobile phase was pumped at 
a rate of 1.0 mL/min at room temp. 20 µL of sample was 
injected each time using rheodyne manual injector. For 
the detection,the wavelength was set at 298 nm and the 
peak areas integration was performed using LC solution 
software.
Methodology for stress testing
Specificity of the developed method was proved by 
stress degradation studies where the drug was intentionally 
degraded under different stress conditions as specified by 
ICH. 
Stress studies were performed by subjecting CEF 
standard solutions to forced degradation by acidic 
(1 N HCl), basic (0.1 N NaOH), neutral hydrolytic (purified 
water) and oxidative degradation (3% H2O2) conditions. A 
stock solution of 1 mg/mL was prepared in methanol. 2 mL 
of solution was treated with 2 mL of each of the reagent 
separately and all the mixtures were kept away from light 
to exclude the possibility of any photolytic degradation. 
The acidic mixture was kept for 24 h after which it was 
neutralised with 1 N NaOH solution and an aliquot was 
diluted with the mobile phase so as to yield 100 µg/mL. 
For the alkaline mixture, prepared with equal volume of 
0.1 N NaOH, it was observed that the drug peak disappeared 
after 30 min, along with many extra peaks indicating that 
the alkaline degradation was vigorous. Hence the mixture 
FIGURE 1 - Structure of cefixime trihydrate (CEF).
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was kept for 10 min after which it was neutralized with 
0.1 N HCl and an aliquot was diluted with the mobile phase 
to yield 100 µg/mL. Neutral degradation was done in an 
identical manner using purified water and the mixture was 
kept for 48 h for the possible degradation, but excluding 
any neutralization procedure. For oxidative degradation the 
stock solution was treated with equal volume of 3% H2O2 
solution, kept for 2 h at room temp after which 100 µg/mL 
solution was prepared from that for injection.
Photolytic degradation was performed on 100 µg/mL 
solution, prepared from dry powder exposed to short UV 
radiations (wavelength = 254 nm) for a period of 24 h. 
Preparation of solutions for injection
10 mg of the reference substance was dissolved in 
10 mL of methanol (1000 µg/mL). The working standard 
solution (100 µg/mL) was prepared by dilution of the stock 
solution using mobile phase.
A quantity of tablet powder equivalent to 25 mg of 
CEF was transferred to a 25 mL volumetric flask and added 
10 mL of methanol, kept in an ultrasonic bath for 10 min 
and made upto the volume with methanol and filtered.
Validation study
The developed method was validated as per ICH 
guidelines with respect to the following parameters: 
accuracy, precision, LOD, LOQ, specificity, robustness, 
stability and system suitability. All the solutions required 
for validation data were prepared with cefixime standard.
Linearity
For testing linearity seven calibration standards were 
prepared in the range of 5 to 100 µg/mL (5, 10, 20, 40, 
60, 80 and 100 µg/mL). Standard curve was obtained by 
plotting peak area against concentration and the evaluation 
of linearity was done by linear regression analysis using 
least square method.
Limit of detection and limit of quantitation
Limit of detection (LOD) and limit of quantitation 
(LOQ) were estimated at a signal to noise ratio of 3:1 and 
10:1 respectively by injecting a series of dilute solutions 
of known concentration.
Robustness
Experimental conditions were deliberately altered, 
in order to determine the robustness. From the different 
experimental conditions such as flow rate (1.0 mL/min), 
lambda max (298 nm) and percentage of methanol (25), 
each selected factor was changed at three levels (-1, 0, +1).
Each factor was changed at a time to study the impact of 
the change in the experimental conditions on the assay 
results. Change in the in the peak area and the retention 
time were noted at for each change in the analytical 
parameters.
Stability of sample solution
Sample solution was prepared and analysed by the 
HPLC instrument using fresh mobile phase at different 
time intervals (0 h, 8 h and 24 h).
Accuracy
Accuracy of the developed method was assessed in 
triplicate at three concentrations (40, 60 and 80 µg/mL). 
The percentage recovery was calculated from the linear 
regression equation obtained in the linearity studies.
Precision
The precision of the analytical method was evaluated 
by the determination of the repeatability of the method 
(intra day precision) and intermediate precision (inter 
day precision) of the sample solutions. Repeatability was 
calculated by assaying six samples prepared on the same 
day. Intermediate precision was calculated by assaying 3 
days. The relative standard deviation of the area of peaks 
was calculated.
RESULTS AND DISCUSSION
UV spectral analysis
In order to identify the absorption peaks in the 
UV region, a scan of cefixime trihydrate was taken in 
methanolic solution of phosphate buffer (25:75), which 
indicated that 289 nm was the absorption maximum 
(λmax).
Optimization of chromatographic conditions
To analyze cefixime trihydrate together with its 
possible degradation products, reverse phase LC in 
combination with UV detector was developed, optimized 
and validated. After trials with different mobile phase 
compositions, a satisfactory separation for the drug and 
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its degradation products were obtained with mobile phase 
consisting of 10 mM disodium hydrogen phosphate with 
0.5% TEA (pH adjusted to 6.3 with OPA) and methanol in 
the ratio of 75:25 (v/v), pumped at a flow rate of 1 mL/min. 
The detection was carried out at 289 nm and the retention 
time was found to be 6.81 min.
Calibration plot for cefixime trihydrate
A linear calibration plot for the method was obtained 
over the calibration range of 5 – 100 µg/ml at a wavelength 
of 289 nm. The equation of the regression line was found 
to be y =84923x+36508 with a correlation coefficient of 
0.9997.The results showed that an excellent correlation 
exists between the peak area and concentration of the 
analyte.
Analysis of the marketed formulations
The proposed method was evaluated by the assay 
of commercially available tablets (formulation-I and 
formulation- II) containing cefixime trihydrate (200 mg). 
The results obtained for cefixime trihydrate was compared 
with the corresponding labeled amounts and reported 
in Table I. The amount of cefixime trihydrate found in 
formulation - I (Cefigip) and formulation II (Taxim - 
O) was 202.37 mg and 203.77 mg respectively. These 
amounts are within the limits. For both formulation-I and 
formulation- II the %RSD was less than 2, which indicated 
the accuracy of the proposed method.
Stress degradation studies
Cefixime trihydrate was found to degrade under 
acidic condition(1N HCl). The degradation reaction was 
more intense and quicker in alkaline condition because the 
std solution resulted from the alkaline mixture, prepared 
with an equal volume of 0.1N NaOH, the drug peak 
disappeared after 30 min, along with many extra peaks. 
Hence, the reaction time was reduced to 10 min. In the 
absence of acid or base also, it undergoes hydrolysis, which 
is revealed by the presence of extra peaks. Upon treatment 
with 3% v/v H2O2 at room temperature, it was found that 
the drug was degraded. Additional peaks were observed 
after 24 h exposure to UV light indicating that the drug is 
not photostable.
The chromatograms obtained under different stress 
conditions are in Figure 2. 1 to 5 and the CEF std drug peak 
is labelled in all chromatograms. The resolution was found 
to be more than 2 in all the cases.
Method validation
The method was validated for all validation 
parameters as per ICH guidelines. The linear regression 
data for the calibration curve (n = 3) showed good linear 
relationship over the concentration range 5-100 μg/mL. 
No significant difference was observed in the slopes of 
standard curves.
Precision
The repeatability (intra-day precision) of the 
method was determined by intra-day (n=3) analysis 
of three standard solutions of cefixime trihydrate at 
the concentration of 5, 20 and 40 µg/mL. Intermediate 
precision was determined by the inter-day (n=6) analysis 
of three standard solutions of cefixime trihydrate at the 
concentration of 5, 20 and 40 µg/ml. The data obtained 
TABLE I - Assay for tablet formulations
S.NO. Formulation Labelled Claim (mg)
Amount found (mg) 
Mean ± SD Assay (%) %RSD
1 Cefigip 200 202.379 ± 1.983 101.19 0.984
2 Taxim-O 200 203.773 ± 1.657 101.89 0.813
FIGURE 2-1 - Chromatogram for oxidative degradation (Rt of 
CEF std = 6.838).
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from precision experiments are given in Table II for intra- 
and inter-day precision studies. The % RSD values for 
intra-day and inter-day study were < 2.0%, confirming 
that the method was precise. 
FIGURE 2-2 - Chromatogram for alkaline degradation (Rt of 
CEF std = 6.845).
FIGURE 2-5 - Chromatogram for photolytic degradation (Rt of 
CEF std = 6.890).
FIGURE 2-4 - Chromatogram for hydrolytic degradation (Rt 
of CEF std = 6.91).
FIGURE 2-3 - Chromatogram for acidic degradation (Rt of CEF 
std = 6.791).
Accuracy (recovery studies)
The proposed method when used for extraction 
and subsequent estimation of cefixime trihydrate from 
TABLE II - Data for precision
Concentration 
(µg/mL)
Intra-day Precision (n=3) Inter-day Precision (n=6)
Amount SD %RSD Amount SD %RSD
5 6.029 0.012 0.200 6.010 0.023 0.387
20 19.629 0.065 0.331 19.382 0.303 1.567
40 39.003 0.465 1.192 38.837 0.400 1.029
Acceptance Criteria: % RSD should not be more than 2.
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pharmaceutical formulations after spiking with additional 
drug at three different levels (80%, 100% and 120%) 
afforded recovery of 99.96–101.54% for two formulations 
(Cefigip, Taxim-O), and mean recovery and %RSD for 
cefixime trihydrate from marketed formulations are listed 
in Table III.
Limit of detection (LOD) and limit of 
quantification (LOQ)
From the linearity plot the LOD and LOQ of 
cefixime trihydrate were calculated by equation 1 and 2 
respectively.
 LOD = 3.3 σ/S equation 1
 LOQ = 10 σ/S equation 2
σ = standard deviation of the response and S = slope 
of calibration curve; LOD and LOQ were found to be 
0.0398 µg/mL and 0.120 µg/mL respectively which 
indicate adequate sensitivity of the method.
Robustness
In robustness study, each chromatographic factor 
selected was changed one by one to estimate the effect of 
change on the results. Thus, replicate injections (n = 3) 
of standard solution at three levels were performed with 
small changes in chromatographic parameters (factors). 
Results, presented in Table IV indicated that the selected 
parameters remained unaffected by the small variations in 
these factors. None of the alterations caused a significant 
change in peak area and tailing factor.
System suitability
The system suitability was established by evaluating 
parameters like theoretical plates, tailing factor, retention 
time and resolution. The results of system suitability 
shown in Table V proved that the method is suitable for 
intended purpose.
CONCLUSION
An economical stability-indicating HPLC method 
has been developed and validated for the determination 
of Cefixime trihydrate in API and in pharmaceutical 
formulations. The proposed method is accurate, precise, 
and specific and also has the ability to separate the drug 
from degradation products. The degradation products 
resulting from the forced degradation studies did not 
interfere with the detection of cefixime trihydrate. The 
concentration of drug was found to be changing from the 
initial concentration indicating that cefixime trihydrate 
undergoes degradation under different stress degradation 
conditions.
TABLE III - Data for recovery studies
Tablet 
Excess drug 
added to 
analyte (%)
Theoretical 
content (mg)
Amount found 
(mg)
Recovery 
(%) SD %RSD SE
T 1
0 20 20.16 100.785 0.199 0.987 0.114
80 36 36.51 101.416 0.132 0.362 0.076
100 40 40.32 100.8 0.236 0.585 0.136
120 44 44.18 100.4 0.102 0.231 0.059
T 2
0 20 20.31 101.54 0.165 0.810 0.095
80 36 36.534 101.48 0.079 0.218 0.046
100 40 39.986 99.96 0.072 0.180 0.042
120 44 44.386 100.88 0.354 0.797 0.204
T1, T2: (Cefigip, Taxim-O respectively); Acceptance criteria: % RSD should be <2.
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